Interpretation of epicardial mapping by means of computer simulations: applications to calcium, lidocaine and to BRL 34915.
The aim of this work was to compare experimental investigations on effects of lidocaine, calcium and, BRL 34915 on reentries to simulated data obtained by use of a model of propagation based on the Huygens' construction method already described in previous works. Calcium and lidocaine effects are investigated on anisotropic conduction conditions. In both cases, reduction in conduction velocities are observed. In lidocaine case, a refractory area is located along the longitudinal axis. In agreement with experimental electrical mapping, the simulations show that the stabilization of reentrant excitation is mainly due to the existence of this refractory area around which the reentrant circuit can develop. The experimental study shows that BRL 34915 has both arrhythmogenic and antiarrhythmic effects. A detailed electrophysiological analysis has shown that drug infusion act on normal cardiac cells by decreasing the relative and absolute refractory period. BRL 34915 action is simulated by a decrease in the refractory period showing that the time frequency of the reentrant activity is increased and that the spatial size where the reentry is developing is becoming smaller. These two effects are arrhythmogenic, the simulated data being so in good agreement with the experimental ones.
Auger
P
P
Laboratoire d'Ecologie, Université de Bourgogne, Dijon, France.
Cardinal
R
R
Bril
A
A
Rochette
L
L
Bardou
A
A
D000818:Animals; D016880:Anisotropy; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001578:Benzopyrans / Q000494:pharmacology*; D002118:Calcium / Q000494:pharmacology*; D003198:Computer Simulation; D019806:Cromakalim; D004285:Dogs; D004594:Electrophysiology; D006329:Heart Conduction System / Q000187:drug effects*; D008012:Lidocaine / Q000494:pharmacology*; D008955:Models, Cardiovascular; D011758:Pyrroles / Q000494:pharmacology*; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000503:physiopathology*
D000959:Antihypertensive Agents; D001578:Benzopyrans; D011758:Pyrroles; D019806:Cromakalim; D008012:Lidocaine; D002118:Calcium